Onconova Therapeutics to Provide Corporate Update and Second Quarter 2020 Earnings on August 12, 2020


You May Also Like

CoLucid Pharmaceuticals Announces Special Protocol Agreement for SPARTAN

CAMBRIDGE, Mass., March 01, 2016 (GLOBE NEWSWIRE) -- CoLucid Pharmaceuticals, Inc. (NASDAQ:CLCD), a Phase 3 ...

R1 RCM Reports Second Quarter 2018 Results

CHICAGO, Aug. 09, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider ...